Antegren

E1583699 UNEXPLORED

Antegren is a monoclonal antibody drug (natalizumab) developed for the treatment of multiple sclerosis and Crohn’s disease.

All labels observed (1)

Label Occurrences
Antegren canonical 1

How this entity was disambiguated

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Elan Corporation plc notableProduct Antegren
subject linked to: NYSE:ELN